Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

How patients in Denmark acquire their medicines: overview, data sources and implications for pharmacoepidemiology

Publikation: Bidrag til tidsskriftReviewpeer review

DOI

  1. Camostat mesylate against SARS-CoV-2 and COVID-19-Rationale, dosing and safety

    Publikation: Bidrag til tidsskriftReviewpeer review

  2. BCPT policy for experimental and clinical studies

    Publikation: Bidrag til tidsskriftLederpeer review

  3. COVID-19 clinical trials: Ethical and scientific consequences of the RECOVERY trial results

    Publikation: Bidrag til tidsskriftLetterpeer review

  4. Active chlordiazepoxide metabolites in a patient needing life support after treatment of alcohol abstinence

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Polypharmacy in schizophrenia

    Publikation: Bidrag til tidsskriftReviewpeer review

  1. Low-dose aspirin for primary and secondary prevention of cardiovascular events in Denmark 1998-2018

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Treatment patterns in patients with treatment-resistant depression in Danish patients with major depressive disorder

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

The means by which patients acquire their medications differ between countries, and a knowledge of this is essential when conducting and interpreting pharmacoepidemiological studies. The aim of this paper is to provide an overview of how patients obtain medicines in Denmark, to relate these to nationwide registries available for research and to discuss the implications for research. Health services are predominantly tax-funded in Denmark, with dentistry and some medicine bought at community pharmacies being exceptions, involving partial reimbursement of charges. The paper gives an overview of prescription medicines acquired from community pharmacies (including magistral preparations), over-the-counter medicines, vaccinations and in-hospital medicine including so-called "free medicine" (in Danish: "vederlagsfri medicin"). "Free medicine" is medicines for a defined list of diseases and indications that is provided free of charge to patients in outpatient clinics. The paper also describes the content of the various Danish data sources about medicine use, summarizes their strengths and limitations, and exemplifies the ways of evaluating their completeness. An example is provided of the regional variation in the means by which medicines are acquired.

OriginalsprogEngelsk
TidsskriftBasic & clinical pharmacology & toxicology
Vol/bind128
Udgave nummer1
Sider (fra-til)46-51
Antal sider6
ISSN1742-7843
DOI
StatusUdgivet - jan. 2021

Bibliografisk note

© 2020 Nordic Association for the Publication of BCPT (former Nordic Pharmacological Society).

ID: 61311313